Join the Diabetes, Type 2 group to help and get support from people like you.
Diabetes, Type 2 News (Page 11)
Related terms: Noninsulin-dependent Diabetes, Type 2 Diabetes, Diabetes, Type 2
Websites Selling Compounded GLP-1 RAs Often Misinform Consumers
TUESDAY, Jan. 21, 2025 – Websites that sell compounded glucagon-like peptide-1 receptor agonists (GLP-1 RAs) often partially inform or misinform consumers, including with respect to U.S. Food and...
No Link Seen Between GLP-1 Receptor Agonist Use and Thyroid Cancer
WEDNESDAY, Jan. 22, 2025 – Glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is not associated with an increased risk for thyroid cancer over the short term, according to a study published ...
Medicare to Negotiate Prices for 15 More Drugs, Including Ozempic
WEDNESDAY, Jan. 22, 2025 – Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with disabilities, federal health officials announced in...
Popular GLP-1 Drugs Are Shaping Health Beyond Weight Loss & Diabetes
TUESDAY, Jan. 21, 2025 – Popular GLP-1 medications for weight loss and diabetes may have unexpected benefits for reducing risks for conditions such as substance abuse, psychosis, infections and even...
Popular GLP-1 Drugs Are Shaping Health Beyond Weight Loss & Diabetes
TUESDAY, Jan. 21, 2025 – Popular GLP-1 medications for weight loss and diabetes may have unexpected benefits for reducing risks for conditions such as substance abuse, psychosis, infections and even...
FDA Proposes New Front-of-Package Food Labels
WEDNESDAY, Jan. 15, 2025 – Grabbing a quick snack might soon come with a little extra clarity. The U.S. Food and Drug Administration (FDA) has proposed a new rule requiring bold, easy-to-read...
Perioperative GLP-1 RA Use Reduces Risk for Complications in Patients With Diabetes
MONDAY, Jan. 13, 2025 – For patients with diabetes undergoing a surgical procedure, an active perioperative glucagon-like peptide-1 receptor agonist (GLP-1 RA) prescription is associated with...
Semaglutide Doubles Risk for Nonarteritic Anterior Ischemic Optic Neuropathy
TUESDAY, Jan. 14, 2025 – Use of once-weekly semaglutide more than doubles the risk for nonarteritic anterior ischemic optic neuropathy (NAION) in individuals with type 2 diabetes, according to a...
Can Carrots Help Treat Type 2 Diabetes?
FRIDAY, Jan. 10, 2025 – Munching on carrots may help benefit your health, especially if you live with type 2 diabetes. At least, that is the hope of researchers in Denmark. "We see carrots as a...
Study Quantifies Global T2DM, CVD Burdens Attributable to Sugary Drinks
WEDNESDAY, Jan. 8, 2025 – Overall, 9.8 percent of all incident type 2 diabetes (T2D) cases and 3.1 percent of incident cardiovascular disease (CVD) cases were attributable to sugar-sweetened...
Diabetes Prevention Program Saves People Money, Study Shows
WEDNESDAY, Jan. 8, 2025 – Preventing diabetes can be as good for a person’s wallet as it is for their health, a new study says. People participating in a diabetes prevention program saved more than $...
Sugary Drinks Are To Blame for Millions of Diabetes, Heart Disease Cases Worldwide
WEDNESDAY, Jan. 8, – Sugar-sweetened drink consumption accounts for more than 2 million new cases of type 2 diabetes, and 1.2 million new cases of heart disease worldwide annually. According to new...
Some GLP-1s Achieve More Weight Loss Than Others: Study
WEDNESDAY, Jan. 8, 2025 – Three GLP-1 drugs are best at helping obese and overweight people drop weight, including one that hasn’t yet been approved for that purpose. A new evidence review published ...
Participation in National Diabetes Prevention Program Is Cost-Saving
TUESDAY, Jan. 7, 2025 – Participants with prediabetes enrolled in the National Diabetes Prevention Program (NDPP) have a reduction in direct medical costs over two years, according to a study...
GLP-1 RAs Efficacious for Weight Loss in Overweight, Obesity Without Diabetes
TUESDAY, Jan. 7, 2025 – For adults with overweight or obesity without diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are efficacious for weight loss, according to a review published...
Further information
Related condition support groups
Related drug support groups
metformin, Ozempic, Mounjaro, Victoza, Lantus, semaglutide, Trulicity, glipizide, Rybelsus, view more... tirzepatide, Jardiance, liraglutide, Lantus Solostar, Humalog, Farxiga, Novolog, Janumet, insulin glargine, Januvia, Bydureon, insulin lispro, Tresiba, dulaglutide, Levemir, insulin degludec, Invokana, glimepiride, Glucophage, Humulin N